Literature DB >> 7457251

Biomechanics of brain edema and effects on local cerebral blood flow.

A Marmarou, H Takagi, K Shulman.   

Abstract

Brain edema represents a disturbance of the volume equilibrium which, in the early stages of formation, must be compensated for by a reduction in other fluid and blood compartments. When this compensation is inadequate, tissue pressure and intracranial pressure increase, the magnitude of which depends on the compliance of the tissue. Tissue pressure gradients develop within the same hemisphere and between hemispheres, but these pressure gradients are transient and dissipate within a few hours after injury. The rate of dissipation is proportional to the product of hydraulic tissue resistance and compliance. These tissue pressure gradients are small in magnitude, less than 15 mm Hg; however, studies with an infusion model of edema in animals show that they are more than sufficient to propel fluid through the parenchyma by a process of bulk flow. The distention caused by the fluid increases the conductance and compliance of the tissue. This biomechanical response favors the dissipation of pressure gradients, and as a result hydrostatic gradients can be sustained only with a continued leakage of fluid from the site of injury. Without a continued extravasation of fluid, equilibration of the tissue pressure to the level of the ICP occurs rapidly. For this reason, the role of hydrostatic gradients in the resorption process may be limited. The development of an infusion model allows more rigid control and simulates the edematous process. Ultrastructural studies of the infusion model have shown that the tissue changes are similar to those reported for vasogenic edema, with the exception that in the infusion model the blood-brain barrier remains intact in the vicinity of the lesion and is not compromised by the mechanical distention of the ECS. The response of the cerebrovasculature to the infusion edema is in contrast to the usual reduction of flow seen after cryogenic injury. The CBF remains constant despite increased tissue water, as confirmed by gravimetric technique. The CO2 reactivity of the vessels in the area of edema is reduced, but the autoregulation to changes in perfusion pressure remains intact. When arterial pressure is raised beyond the limit of autoregulation, the pressure increase of CBF in the edematous area is less than the rise of CBF in normal tissue and suggests a "false autoregulation" caused by an increased tissue pressure. The differences in both the intracranial pressure and CBF response between these two models suggests that other factors must be operative. The cryogenic injury is indeed a traumatic injury to the brain and cannot be simply characterized by the increase in brain tissue water. In some animals a vasomotor paralysis disrupting the vascular compartmental volume and leading to a rapid rise in ICP with eventual reduction of CPP and CBF may explain these differences. Release of vasoactive substances into the ECS is an exciting hypothesis and is an area of investigation ideally suited to the infusion edema process where chemical composition of the fluid can be easily controlled.

Entities:  

Mesh:

Year:  1980        PMID: 7457251

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  23 in total

1.  Brain arterial dilatation modifies the association between extracranial pulsatile hemodynamics and brain perivascular spaces: the Northern Manhattan Study.

Authors:  Jose Gutierrez; Marco DiTullio; Ying Kuen K Cheung; Noam Alperin; Ahmet Bagci; Ralph L Sacco; Clinton B Wright; Mitchell Sv Elkind; Tatjana Rundek
Journal:  Hypertens Res       Date:  2019-04-01       Impact factor: 3.872

2.  The role of bradykinin in the etiology of vasogenic brain edema and perilesional brain dysfunction.

Authors:  I R Whittle; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

3.  Proceedings of the meeting of the Society of British Neurological Surgeons. 115th meeting. Newcastle upon Tyne, 20-22 September 1989. Abstracts.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

4.  Proceedings of the 113th meeting of the Society of British Neurological Surgeons and the joint meeting with the British Society of Neuroradiologists. Glasgow, 22-24 September 1988. Abstracts.

Authors: 
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

Review 5.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

6.  Neoplastic encephalopathy: dynamic CT of cerebral gliomata.

Authors:  J R Jinkins
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

7.  Brain Arterial Diameters and Cognitive Performance: The Northern Manhattan Study.

Authors:  Jose Gutierrez; Erin Kulick; Yeseon Park Moon; Chuanhui Dong; Ken Cheung; Bagci Ahmet; Yaakov Stern; Noam Alperin; Tatjana Rundek; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind
Journal:  J Int Neuropsychol Soc       Date:  2017-11-23       Impact factor: 2.892

8.  Pulsatile and steady components of blood pressure and subclinical cerebrovascular disease: the Northern Manhattan Study.

Authors:  Jose Gutierrez; Mitchell S V Elkind; Ken Cheung; Tatjana Rundek; Ralph L Sacco; Clinton B Wright
Journal:  J Hypertens       Date:  2015-10       Impact factor: 4.844

9.  Observation on peritumoural oedema in meningioma. Part I: Distribution, spread and resolution of vasogenic oedema seen on computed tomography.

Authors:  J M Stevens; J S Ruiz; B E Kendall
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

10.  Neuropathological and neurophysiological effects of interstitial white matter autologous and non-autologous protein containing solutions: further evidence for a glioma derived permeability factor.

Authors:  I R Whittle; J W Ironside; I R Piper; J D Miller
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.